Showing results (101-110 of 119) with videos related to
Sort By:
Pageof 12
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 20, 2010
Effects of preexisting microdamage, collagen cross-links, degree of mineralization, age, and architecture on compressive mechanical properties of elderly human vertebral trabecular boneHelene Follet, Stéphanie Viguet-Carrin, Brigitte Burt-Pichat, et al.Journal of the American Dental Association (1939)|January 3, 2008
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trialJohn T Grbic, Regina Landesberg, Shou-Qing Lin, et al.Bone|October 9, 2007
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosisPierre D Delmas, Michael R McClung, José R Zanchetta, et al.The Journal of Clinical Endocrinology and Metabolism|August 7, 2008
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronatePaul D Miller, Pierre D Delmas, Robert Lindsay, et al.Arthritis and Rheumatism|June 3, 2008
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trialJean-Yves Reginster, Dieter Felsenberg, Steven Boonen, et al.Bone|March 4, 2008
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosisRené Rizzoli, Nansa Burlet, David Cahall, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myelomaHans D Menssen, Adriana Sakalová, Aurélie Fontana, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 12, 2010
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronateEgo Seeman, Pierre D Delmas, David A Hanley, et al.The Journal of Rheumatology|February 9, 2008
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA studyJohn A Eisman, Roberto Civitelli, Silvano Adami, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2005
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronateJean-Yves Reginster, Dieter Felsenberg, Cyrus Cooper, et al.Pageof 12